Alamar Biosciences, Inc. (ALMR) is a Technology stock trading at $25.82 (as of 2026-07-24), with a market capitalization of $1.79B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Alamar Biosciences, Inc. is in the Measuring & Control Equipment industry, but the provided data does not specify what it sells or how it makes money.
The dataset shows a 55.5% gross margin, but an operating margin of -47.4%, so the profit model is structurally constrained by operating expenses that outweigh gross profit.
Business quality (Weak): Insufficient company-specific detail in the provided facts (no business description, no segment breakdown, and no operating KPI metrics), which limits confidence in a retail-focused operating assessment.
| Price | $25.82 |
| Market Cap | $1.79B |
| FCF Yield | -1.9% |
| Revenue (TTM) | $74.21M |
| Net Margin | -40.2% |
| Revenue Growth (YoY) | 98.9% |
| EPS Growth (YoY) | 155.9% |
| FCF Growth (YoY) | 53.8% |
| Altman Z-Score | 2.30 (grey) |
| Sector P/E (Technology) | 34.6 |
| Industry P/E (Measuring & Control Equipment) | 59.4 |
| Sector | Technology |
| Industry | Measuring & Control Equipment |
Data as of 2026-07-24.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.